⌘K

Login Start Free

Home/Filings/4/0001127602-24-030106

4//SEC Filing

Eisele Jeffrey 4

Accession 0001127602-24-030106

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 4:06 PM ET

Size

4.5 KB

Accession

0001127602-24-030106

Insider Transaction Report

Form 4

Period: 2024-12-23

Apellis Pharmaceuticals, Inc.APLS

Chief Development Officer

Transactions

Sale
Common Stock
2024-12-23$33.09/sh−63$2,085→ 57,145 total

Footnotes (1)

[F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on 12/20/2024

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1

filerCIK 0001827326

Filing Metadata

Form type: 4
Filed: Dec 26, 7:00 PM ET
Accepted: Dec 27, 4:06 PM ET
Size: 4.5 KB

View on SEC.gov